Session » Vasculitis Poster II
-
Abstract Number: 1951
The Incidence Rate of Giant Cell Arteritis in Slovenia
-
Abstract Number: 1952
Lack of Association of a 6.7 Kbp Deletion of LILRA3 with Giant Cell Arteritis
-
Abstract Number: 1953
Identification of Genetic Factors Associated with Clinical Manifestations of Giant Cell Arteritis through a Stratified Large-Scale Analysis
-
Abstract Number: 1954
How Can We Use Ultrasound in the Diagnosis and Management of Patients with Giant Cell Arteritis?
-
Abstract Number: 1955
The Performance of Colour-Doppler Sonography of Temporal Arteries in Patients Suspect of Having Giant Cell Arteritis in Daily Clinical Practice
-
Abstract Number: 1956
Risk of Cerebrovascular Accident in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
-
Abstract Number: 1957
Colour-Doppler Ultrasonography of Epiaortic Arteries in Patients with Giant Cell Arteritis
-
Abstract Number: 1958
Diagnostic Value of Ultrasonography-Derived Signs in Giant Cell Arteritis: Literature Review and Meta-Analysis
-
Abstract Number: 1959
Color Doppler Ultrasonography Appears to Perform Better Than Magnetic Resonance Angiography in the Diagnostics of Patients with Systemic Large Vessel Vasculitis
-
Abstract Number: 1960
a Structured and Extensive Training Program on Vascular Ultrasound, Results in an Excellent Agreement Between Ultrasound and Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
-
Abstract Number: 1961
Interobserver Agreement on Ultrasonographic and Magnetic Resonance Angiography Findings in Patients with Large Vessel Vasculitis
-
Abstract Number: 1962
Inter-Rater Analysis of Ultrasound and Histological Findings in Patients with Suspected Giant Cell Arteritis
-
Abstract Number: 1963
Specialty of Provider Referring for Temporal Artery Biopsy Affects the Likelihood of Giant Cell Arteritis (GCA) Diagnosis
-
Abstract Number: 1964
Biomarkers in Temporal Artery Biopsies and Sera of Patients with Giant Cell Arteritis
-
Abstract Number: 1965
T Cell Activation, Proliferation and Differentiation Markers Lack Diagnostic Accuracy for Detecting Active GCA and PMR
-
Abstract Number: 1966
Active PMR and GCA Is Associated with Changes in Monocyte Subset Composition
-
Abstract Number: 1967
Deregulation of Interleukin-22 Pathway in Giant Cell Arteritis
-
Abstract Number: 1968
Distinct Distribution Patterns of Large Vessel Vasculitis Assessed with 18f-FDG PET/CT: Evidence from Principal Component and Cluster Analyses
-
Abstract Number: 1969
Can We Predict the Relapse of Giant Cell Arteritis?
-
Abstract Number: 1970
Incidence and Predictors of Thoracic Aortic Damage in Biopsy-Proven Giant Cell Arteritis: A Single-Institution Cohort Study
-
Abstract Number: 1971
Healthcare Utilization and Direct Medical Costs of Giant Cell Arteritis
-
Abstract Number: 1972
Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis
-
Abstract Number: 1973
Giant Cell Arteritis and Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis
-
Abstract Number: 1974
Do Patients with Giant Cell Arteritis Meet the 2011 United Kingdom Department of Health Guidance on Physical Activity?
-
Abstract Number: 1975
Risk of Mortality of Patients with Giant Cell Arteritis: A Systematic Review and Meta-Analysis
-
Abstract Number: 1976
Corticosteroid Therapy in Giant Cell Arteritis, Predictors for Long-Term Remission
-
Abstract Number: 1977
Long-Term Survival of Methotrexate in Giant Cell Arteritis Patients in Clinical Practice
-
Abstract Number: 1978
Tocilizumab in Refractory Large Vessel Vasculitis with Aorta Involvement. Study on 10 Patients Evaluated By Positron Emission Tomoghraphy
-
Abstract Number: 1979
Baseline Data on Patients Enrolled in a Randomized, Double-Blind Trial of Tocilizumab in Giant Cell Arteritis
-
Abstract Number: 1980
Tocilizumab in Giant Cell Arteritis: A Multicentre Open-Label Study in France
-
Abstract Number: 1981
Increased Extracellular Water Measured By Bioimpedance Analysis in Polymyalgia Rheumatica Patients – Sign of Volume Overload
-
Abstract Number: 1982
Sonographic Scoring of the Synovial Components in the Shoulder Revealed That Shoulder Synovitis in PMR Patients Is Milder Than That in Elderly-Onset RA Patients with PMR-like Onset
-
Abstract Number: 1983
Interspinous Bursitis Evaluation By Ultrasound Is Very Useful for Diagnosis of Polymyalgia Rheumatica
-
Abstract Number: 1984
Incidence and Intensity of 18fdg Uptake on Whole Body PET/CT in Patients with Polymyalgia Rheumatica
-
Abstract Number: 1985
Abnormal B-Cell Distribution Is Improved By Tocilizumab Monotherapy in Patients with Polymyalgia Rheumatica
-
Abstract Number: 1986
Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study.
-
Abstract Number: 1987
Dramatic Efficacy of Tocilizumab As First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study
-
Abstract Number: 1988
Efficacy and Safety of Mizoribine for Polymyalgia Rheumatica: Analysis of 47 Cases
-
Abstract Number: 1989
Treatment of Refractory Non-Infectious Aortitis: Tocilizumab Compared to Antitnf Alfa Agents. Multicenter Study of 44 Patients
-
Abstract Number: 1990
Corticosteroid Use in Idiopathic Aortitis: A Systematic Review
-
Abstract Number: 1991
Large Vessel Involvement By IgG4-Related Disease